Neutrophil gelatinase-associated apolipoprotein in patients with iodine-contrast nephropathy
Sun, M.Z.; Chen, H.M.; Zhou, Z.W.; Jin, H.; Ji, Y.Q.; Ji, J.W.; Fu, Q.P.; Zhang, L.Z.; Wu, Q.Q.; Ju, H.X.
Journal of Biological Regulators and Homeostatic Agents 33(4): 1171-1176
2019
ISSN/ISBN: 0393-974X PMID: 31332985 Document Number: 697950
Document emailed within 1 workday
Related Documents
Wang, L.; Pu, X. 2014: Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy Zhonghua Xin Xue Guan Bing Za Zhi 42(4): 301-304Eremenko, A.A.; Minbolatova, N.M.; Kaabak, M.M.; Babenko, N.N. 2014: Neutrophil gelatinase-associated lipocalin (u-NGAL) in the assessment of renal function in patients after kidney allotransplantation Anesteziologiia i Reanimatologiia 59(5): 10-15
Worasuwannarak, S.; Pornratanarangsi, S. 2010: Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio Journal of the Medical Association of Thailand 93 Suppl. 1: S29-S34
Ilkhanoff, L.; Carver, J. 2005: Contrast-induced nephropathy and cardiac catheterization: evidence in support of using the iso-osmolar contrast agent iodixanol in patients with renal dysfunction Journal of Invasive Cardiology 17(4): 216-217
Zang, Z.-d.; Huang, Y.-z.; Yang, Y.; Guo, F.-m.; Qiu, H.-b. 2010: Urinary neutrophil gelatinase-associated lipocalin and urinary interleukin-18 in early diagnosis of acute kidney injury in critically ill patients Zhonghua Nei Ke Za Zhi 49(5): 396-399
Thanakitcharu, P.; Jirajan, B. 2014: Determination of urinary neutrophil gelatinase-associated lipocalin (NGAL) cut-off level for early detection of acute kidney injury in Thai adult patients undergoing open cardiac surgery Journal of the Medical Association of Thailand 97(Suppl 11): S48-S55
Dwipa, L.; Soelaeman, R.; Roesli, R.M.; Martanto, E.; Adhiarta, I.G. 2012: Cardiometabolic risk factors and acute kidney injury based on urinary neutrophil gelatinase associated lipocalin (NGALu) in acute coronary syndrome patients Acta Medica Indonesiana 44(1): 3-9
Kalousek, I.; Röselová, P.; Otevrelová, P. 2006: NGAL--neutrophil gelatinase associated lipocalin in biochemistry, physiology and clinical praxis Casopis Lekaru Ceskych 145(5): 373-376
Nijssen, E.C.; Rennenberg, R.J.; Nelemans, P.J.; Essers, B.A.; Janssen, M.M.; Vermeeren, M.A.; van Ommen, V.; Wildberger, J.E. 2018: Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial Nederlands Tijdschrift Voor Geneeskunde 161: D1734
Orsolya, M.; Attila-Zoltan, M.; Gherman, V.; Zaharie, F.; Bolboaca, S.; Chira, C.; Bodolea, C.; Tomuleasa, C.; Irimie, A.; Coman, I.; Ionescu, D. 2015: The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology Journal of BUON: Official Journal of the Balkan Union of Oncology 20(1): 317-324
Gundlach, P.J.; van Beek-Peeters, J.A.M.J.; Ruissen, J.; Verberk-Jonkers, I.J.A.M. 2015: Contrast-induced nephropathy and mortality after contrast-based investigation Nederlands Tijdschrift Voor Geneeskunde 159: A8501
Caixeta, A.; Nikolsky, E.; Mehran, R. 2008: Contrast-induced nephropathy: prevention and management of high-risk patients Indian Heart Journal 60(6): 524-531
Gomes, V.O.; Blaya, P.; Poli de Figueiredo, C.E.; Manfroi, W.; Caramori, P. 2003: Contrast-media induced nephropathy in patients undergoing coronary angiography Journal of Invasive Cardiology 15(6): 304-310
Hoshino, A.; Enomoto, S.; Kawahito, H.; Kurata, H.; Nakahara, Y.; Nakamura, T. 2007: Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents Journal of Cardiology 50(2): 119-126
De Mauri, A. 2009: Contrast-induced nephropathy: a contrast without a winner Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 26(2): 141
Zhao, Y.-y.; Liu, D.-w.; Wang, J.-s.; Ouyang, J.; Zhang, W.-z.; Zhang, W.-j.; Meng, J.-q.; Tang, J.-m. 2012: Risk factors of contrast-induced nephropathy in patients after coronary artery intervention Zhonghua Yi Xue Za Zhi 92(22): 1547-1549
Okada, Y.; Naka, K.; Kawamura, K.; Matsumoto, T.; Nakanishi, I.; Fujimoto, N.; Sato, H.; Seiki, M. 1995: Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption Laboratory Investigation; a Journal of Technical Methods and Pathology 72(3): 311-322
Liu, Y.; Liu, Y.; Chen, J.; Chen, J.; Chen, S.; Ye, P.; Tan, N.; Li, H. 2014: The correlation of anemia and contrast-induced nephropathy in patients with chronic kidney disease undergoing percutaneous coronary intervention Zhonghua Nei Ke Za Zhi 53(3): 168-173
Eto, M.; Saito, M.; Kaku, K. 2001: Apolipoprotein e epsilon 2 allele and diabetic nephropathy Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 3): 807-811
Chong, E.; Shen, L.; Poh, K.K.; Tan, H.C. 2012: Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention Singapore Medical Journal 53(3): 164-169